References
- American Diabetes Association Diagnosis and classification of diabetes mellitus. Diabetes Care. 2011;34(Suppl):S62–S69.
- Sacks DB, Arnold M, Bakris GL, et al. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem. 2011;57(6):e1–e47. doi:10.1373/clinchem.2010.161596
- Bonora E, Tuomilehto J. The pros and cons of diagnosing diabetes with A1c. Diabetes Care. 2011;34(Suppl2):S184–S190.
- Florkowski C. Hb A1c as a diagnostic test for diabetes mellitus - reviewing the evidence. Clin Biochem Rev. 2013;34(2):75–83.
- Jaisson S, Leroy N, Meurice J, et al. First evaluation of Capillarys 2 Flex Piercing® (Sebia) as a new analyzer for Hb A1c assay by capillary electrophoresis. Clin Chem Lab Med. 2012;50(10):1769–1775.
- Urrechaga E. High-resolution HbA(1c) separation and hemoglobinopathy detection with capillary electrophoresis. Am J Clin Pathol. 2012;138(3):448–456.
- Mosca A, Paleari R, Ivaldi G, et al. The role of haemoglobin A(2) testing in the diagnosis of thalassaemias and related haemoglobinopathies. J Clin Pathol. 2009;62(1):13–17.
- Chan OT, Westover KD, Dietz L, et al. Comprehensive and efficient HBB mutation analysis for detection of beta-hemoglobinopathies in a pan-ethnic population. Am J Clin Pathol. 2010;133(5):700–707.
- Craig JE, Barnetson RA, Prior J, et al. Rapid detection of deletions causing delta beta thalassemia and hereditary persistence of fetal hemoglobin by enzymatic amplification. Blood. 2004;83(6):1673–1682.
- Patrinos GP, Giardine B, Riemer C, et al. Improvements in the HbVar database of human hemoglobin variants and thalassemia mutations for population and sequence variation studies. Nucleic Acids Res. 2004;32(Database issue):D537-D541 (http://globin.cse.psu.edu/hbvar/).
- Cao A, Kan YW. The prevention of thalassemia. Cold Spring Harb Perspect Med. 2013;3(2):a011775. doi: 10.1101/cshperspect.a011775
- Cousens NE, Gaff CL, Metcalfe SA, et al. Carrier screening for β-thalassemia: a review of international practice. Eur J Hum Genet. 2010;18(10):1077–1083.
- Northern California Comprehensive Thalassemia Center. UCSF Benioff Children’s Hospital Oakland. The demographics of thalassemia (http://thalassemia.com/demographics.aspx#gsc.tab=0). [cited 2016 May 5].
- Old J, Angastiniotis M, Eleftheriou A, et al. Prevention of Thalassaemias and other Haemoglobin Disorders, 2nd ed. Nicosia (Cyprus): Thalassaemia International Federation Publishers. 2013;1:1?8 (http://ukts.org/pdfs/tifpubs/preventionv1.pdf).
- Pereira M, del M, Dalmau AC, et al. Molecular heterogeneity of β-thalassemia alleles in Spain and its importance in the diagnosis and prevention of β-thalassemia major and sickle cell disorders. Hemoglobin. 2009;33(3-4):226–234.
- Moreno Miralles I, Bolufer Gilabert P, Pérez Sirvent M. [The molecular changes in thalassemias in Spain. A review of existing studies]. Med Clin (Barc). 1999;113(20):789–794.
- Villegas A. [Hemoglobinopathies in the Spanish and emigrant population]. An Med Interna. 2006(5);23:203–205.
- Sheiner E, Levy A, Yerushalmi R, et al. β-Thalassemia minor during pregnancy. Obstet Gynecol. 2004;103(6):1273–1277.
- Ribeiro ML, Gonçalves P, Cunha E, et al. Genetic heterogeneity of β-thalassemia in populations of the Iberian Peninsula. Hemoglobin. 1997;21(3):261–269.
- John N. A review of clinical profile in sickle cell traits. Oman Med J. 2010;25(1):3–8.
- Gargallo MA, González FA, Villegas A. Abnormally low Hb A1c secondary to Hemoglobin J-Baltimore [β16(A13)Gly→Asp]. Family study. Endocrinol Nutr. 2010;57(2):83–85.
- Mosca A, Palearei R, Leone D, et al. The relevance of Hemoglobin F measurement in the diagnosis of thalassemias and related hemoglobinopathies. Clin Biochem. 2009;42(18):1797–1801.
- Feuchtbaum L, Carter J, Dowray S, et al. Birth prevalence of disorders detectable through newborn screening by race/ethnicity. Genet Med. 2012;14(11):937–945.